---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-000681"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2025-01-23T23:59:59+00:00"
generated_at: "2026-05-27T15:43:56.469580+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Dermata raises $2.55M private placement at $1.27/unit with insider participation

## Summary
- Gross proceeds $2.55M; net ~$2.4M from 2,007,880 shares (or pre-funded warrants) and same number of warrants.
- Warrants exercisable at $1.27/share upon stockholder approval and expire five years later.
- Insiders (CEO, CFO, board) purchased ~$1.55M of offering at same $1.27/unit price.
- Net proceeds plus cash expected to fund operations into Q3 2025.
- H.C. Wainwright served as placement agent; resale registration statement to be filed.

## SEC filing metadata
- accession: 0001654954-25-000681
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2025-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495425000681/0001654954-25-000681-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495425000681/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-000681
- JSON: https://secwatch.observer/filing/0001654954-25-000681.json
- Plain text: https://secwatch.observer/filing/0001654954-25-000681.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.